Maze Therapeutics, Inc. (MAZE)
42.60
+1.11
(+2.68%)
USD |
NASDAQ |
Dec 04, 16:00
42.58
-0.02
(-0.06%)
After-Hours: 20:00
Maze Therapeutics Shareholders Equity (Quarterly): 379.44M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CDT Equity, Inc. | 4.278M |
| LENZ Therapeutics, Inc. | 193.93M |
| Liminatus Pharma, Inc. | -1.646M |
| Oruka Therapeutics, Inc. | 486.79M |
| MapLight Therapeutics, Inc. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 422.06M |
| Total Liabilities (Quarterly) | 42.62M |
| Debt to Equity Ratio | 0.0637 |
| Current Ratio | 17.70 |
| Net Debt Paydown Yield | -0.39% |